FSSAI Advertising and Claims Regulations, 2018

Governance / Food Safety · Friday, 21 August 2026

The Maharashtra FDA issued notices to actors over Vimal Elaichi endorsements, alleging surrogate advertising of prohibited pan masala. The FSSAI regulations require truthful and scientifically supported food advertising while prohibiting misleading claims, surrogate promotion and unauthorized disease-treatment claims.

Quick highlights

Context

The Maharashtra Food and Drug Administration issued notices concerning endorsements of Vimal Elaichi, alleging that the advertisements functioned as surrogate promotions for prohibited pan masala.

Key Facts

The regulations were framed under Section 92 read with Sections 23 and 24 of the Food Safety and Standards Act, 2006. They apply to Food Business Operators, advertisers and marketers and regulate nutritional, comparative and health claims.

Significance

The framework protects consumers from deceptive marketing and ensures that health or nutrition claims are supported by validated methods and evidence. It also prevents the FSSAI logo from being used as a badge implying product superiority.

Challenges / Way Forward

Surrogate advertising, celebrity endorsements and brand extensions can obscure the product actually being promoted. Strong monitoring, scientific scrutiny of claims, prompt corrective advertisements and enforcement of penalties are necessary.

Exam Angle

Revise FSSAI’s statutory basis, truthful advertising principles, disease-cure prohibitions, prior approval for novel claims, corrective advertisements and liability for misleading commercial communication.

Remember this

More from Friday, 21 August 2026

Full Friday, 21 August 2026 edition with MCQs